Literature DB >> 29721981

Constitutive Activation Mutant mTOR Promote Cone Survival in Retinitis Pigmentosa Mice.

Ammaji Rajala1,2, Yuhong Wang1,2, Raju V S Rajala3,4,5,6.   

Abstract

Studies form our laboratory and others show that the oncogenic tyrosine kinase and serine threonine kinase signaling pathways are essential for cone photoreceptor survival. These pathways are downregulated in mouse models of retinal degenerative diseases. In the present study, we found that activation mutants of mTOR delayed the death of cones in a mouse model of retinal degeneration. These studies suggest that oncogenic protein kinases may be useful as therapeutic agents to treat retinal degenerations that affect cones.

Entities:  

Keywords:  Cone photoreceptors; Insulin receptor; Oncogene; Protein kinases; Retinal degeneration; Retinitis pigmentosa; Survival; mTOR

Mesh:

Substances:

Year:  2018        PMID: 29721981      PMCID: PMC6424566          DOI: 10.1007/978-3-319-75402-4_61

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

1.  Therapeutic Benefits from Nanoparticles: The Potential Significance of Nanoscience in Retinal Degenerative Diseases.

Authors:  Raju V S Rajala
Journal:  J Mol Biol Ther       Date:  2019

Review 2.  Targeting Lipid Metabolism for the Treatment of Age-Related Macular Degeneration: Insights from Preclinical Mouse Models.

Authors:  Michael Landowski; Catherine Bowes Rickman
Journal:  J Ocul Pharmacol Ther       Date:  2021-11-17       Impact factor: 2.671

Review 3.  Retina Metabolism and Metabolism in the Pigmented Epithelium: A Busy Intersection.

Authors:  James B Hurley
Journal:  Annu Rev Vis Sci       Date:  2021-06-08       Impact factor: 6.422

4.  Tribbles homolog 3-mediated targeting the AKT/mTOR axis in mice with retinal degeneration.

Authors:  Irina V Saltykova; Asif Elahi; Priyam M Pitale; Oleg S Gorbatyuk; Mohammad Athar; Marina S Gorbatyuk
Journal:  Cell Death Dis       Date:  2021-07-02       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.